Skip to main
LXRX
LXRX logo

Lexicon Pharmaceuticals (LXRX) Earnings Dates & Reports

Lexicon Pharmaceuticals (LXRX) Most Recent Earnings

Report DateAug 6, 2025
Period EndingQ2 2025
Est. EPS-$0.08
Actual EPS$0.01
EarningsBeat

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Lexicon Pharmaceuticals (LXRX) Earnings per Share (EPS) History

Signup for full access
Browse free

Lexicon Pharmaceuticals (LXRX) Latest Earnings

The value each LXRX share was expected to gain vs. the value each share gained.

Lexicon Pharmaceuticals (LXRX) reported its most recent earnings on Aug 6, 2025 for Q2 2025, posting earnings per share (EPS) of $0.01. This exceeded analysts' expectations of -$0.08 by 112.50%, marking a Beat.

For comparison, Lexicon Pharmaceuticals reported EPS of -$0.17 in the same quarter last year.

The company is expected to announce its next earnings report on 11/11/2025, with analysts projecting an EPS of -$0.07.

Lexicon Pharmaceuticals (LXRX) Earnings History

Earnings
Est. EPSActual EPSSurprise
Q3 2025Nov 11, 2025
-$0.07Next earnings call Nov. 11, 2025
Q2 2025Aug 6, 2025
-$0.08$0.01-112.50%
Q1 2025May 13, 2025
-$0.10-$0.07-30.00%
Q4 2024Mar 6, 2025
-$0.12-$0.09-25.00%
Q3 2024Nov 12, 2024
-$0.16-$0.18+12.50%
View all

Lexicon Pharmaceuticals (LXRX) Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Lexicon Pharmaceuticals’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
Aug 6, 2025
May 13, 2025
Mar 6, 2025
Nov 12, 2024

Lexicon Pharmaceuticals (LXRX) Earnings FAQs

Lexicon Pharmaceuticals (LXRX) last reported earnings on Aug 6, 2025 for Q2 2025, posting an EPS of $0.01, which Beat the estimate of -$0.08 by 112.50%.

For Q2 2025, Lexicon Pharmaceuticals (LXRX) reported an EPS of $0.01, exceeding analysts' estimate of -$0.08 by 112.50%.

For Q2 2025, Lexicon Pharmaceuticals (LXRX) Beat expectations with an actual EPS of $0.01 vs. an estimated EPS of -$0.08.

Following the last earnings report on Aug 6, 2025, Lexicon Pharmaceuticals (LXRX)'s stock price moved — from — to —.

The next Lexicon Pharmaceuticals (LXRX) earnings call is scheduled for Nov. 11, 2025, where executives will discuss financial results and outlook.

Lexicon Pharmaceuticals (LXRX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.